Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$758K Buy
6,303
+167
+3% +$19.3K 0.15% 104
2025
Q4
$646K Buy
6,136
+90
+1% +$8.45K 0.12% 109
2025
Q3
$507K Buy
6,046
+1,120
+23% +$92.2K 0.1% 126
2025
Q2
$390K Sell
4,926
-21
-0.4% -$1.67K 0.1% 111
2025
Q1
$444K Sell
4,947
-32
-0.6% -$2.99K 0.11% 113
2024
Q4
$495K Sell
4,979
-421
-8% -$43.4K 0.12% 106
2024
Q3
$613K Sell
5,400
-260
-5% -$30.9K 0.14% 101
2024
Q2
$701K Sell
5,660
-75
-1% -$9.66K 0.17% 88
2024
Q1
$757K Hold
5,735
0.19% 88
2023
Q4
$625K Sell
5,735
-120
-2% -$12.5K 0.16% 94
2023
Q3
$603K Hold
5,855
0.18% 89
2023
Q2
$676K Sell
5,855
-251
-4% -$28.5K 0.19% 87
2023
Q1
$650K Buy
6,106
+200
+3% +$21.6K 0.19% 89
2022
Q4
$655K Buy
+5,906
New +$604K 0.2% 81

Other funds holding MRK

Legacy Trust's MRK Position: Q1 2026 in Review

Legacy Trust increased its Merck (MRK) stake by 2.7% in Q1 2026, buying an estimated $19.3K and bringing the position to 6,303 shares worth $758K. The position accounts for 0.15% of the portfolio, ranked #104.

Legacy Trust first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Legacy Trust held 6,303 shares of Merck worth $758K as of Q1 2026.
  • Legacy Trust bought 167 Merck shares in Q1 2026, an estimated $19.3K.
  • Merck made up 0.15% of Legacy Trust's portfolio in Q1 2026, its #104 holding.
  • Legacy Trust first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.